(S)-5-((1-(((4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl)oxy)carbonyl)piperidin-4-yl)amino)pentanoicacid; 4-[(4-Carboxybutyl)amino]-1-piperidinecarboxylic Acid (4S)-4,11-Diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl Ester; APC; RPR 121056;
Irinotecan Related Compound(RPR 121056) is a fully characterized chemical compound used as a reference standard of API Irinotecan. The standard offered is compliant with regulatory guidelines. Irinotecan Related Compound(RPR 121056) is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 181467-56-1
Related products
Irinotecan EP Impurity L HCl (R-Irinotecan HCl)
M.F.
M.W. 586.69 36.46
CAT# AR-I01717
CAS# 1992961-26-8
Irinotecan EP Impurity E ((S)-7-Ethyl-10-Hydroxy Camptothecin)
M.F.
M.W. 392.40
CAT# AR-I01722
CAS# 86639-52-3
